191 related articles for article (PubMed ID: 30080117)
1. [Neuropsychiatric manifestations in Tuberous Sclerosis Complex (TSC): diagnostic guidelines, TAND concept and therapy with mTOR inhibitors].
Waltereit R; Feucht M; de Vries MC; Huemer J; Roessner V; de Vries PJ
Z Kinder Jugendpsychiatr Psychother; 2019 Mar; 47(2):139-153. PubMed ID: 30080117
[TBL] [Abstract][Full Text] [Related]
2. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric comorbidities in tuberous sclerosis complex patients with epilepsy: results of the TAND checklist survey.
Lee HY; Lin CH; Wang XA; Tsai JD
Acta Neurol Belg; 2024 Jun; 124(3):973-979. PubMed ID: 38523222
[TBL] [Abstract][Full Text] [Related]
4. Tuberous sclerosis: a review of the past, present, and future.
Uysal SP; Şahin M
Turk J Med Sci; 2020 Nov; 50(SI-2):1665-1676. PubMed ID: 32222129
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice.
Koike-Kumagai M; Fujimoto M; Wataya-Kaneda M
Neuropharmacology; 2022 Nov; 218():109203. PubMed ID: 35931213
[TBL] [Abstract][Full Text] [Related]
6. Involvement of mental health professionals in the treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey.
Waltereit R; Beaure d'Augères G; Jancic J; Kingswood JC; Koleva M; Marques R; Villanueva V; Auvin S
Orphanet J Rare Dis; 2021 May; 16(1):216. PubMed ID: 33980296
[TBL] [Abstract][Full Text] [Related]
7. International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
de Vries PJ; Heunis TM; Vanclooster S; Chambers N; Bissell S; Byars AW; Flinn J; Gipson TT; van Eeghen AM; Waltereit R; Capal JK; Cukier S; Davis PE; Smith C; Kingswood JC; Schoeters E; Srivastava S; Takei M; Gardner-Lubbe S; Kumm AJ; Krueger DA; Sahin M; De Waele L; Jansen AC
J Neurodev Disord; 2023 Sep; 15(1):32. PubMed ID: 37710171
[TBL] [Abstract][Full Text] [Related]
8. The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.
Vanclooster S; Bissell S; van Eeghen AM; Chambers N; De Waele L; Byars AW; Capal JK; Cukier S; Davis P; Flinn J; Gardner-Lubbe S; Gipson T; Heunis TM; Hook D; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; Waltereit R; Jansen AC; de Vries PJ
J Neurodev Disord; 2022 Feb; 14(1):13. PubMed ID: 35151277
[TBL] [Abstract][Full Text] [Related]
9. Tuberous Sclerosis Complex Patients' Needs and Difficulties-Results of TAND Questionnaire Analysis in Polish Adult Population.
Marcinkowska AB; Jóźwiak S; Tarasewicz A; Dębska-Ślizień A; Szurowska E
J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362764
[TBL] [Abstract][Full Text] [Related]
10. Measurement of Developmental and Behavioral Concerns in Toddlers With Tuberous Sclerosis Complex.
McDonald NM; Jacobs S; Hyde C; Kasari C; Jeste SS
Pediatr Neurol; 2024 Jun; 155():62-67. PubMed ID: 38603983
[TBL] [Abstract][Full Text] [Related]
11. Development and Feasibility of the Self-Report Quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ).
Heunis TM; Chambers N; Vanclooster S; Bissell S; Byars AW; Capal JK; Cukier S; Davis PE; de Vries MC; De Waele L; Flinn J; Gardner-Lubbe S; Gipson T; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; van Eeghen AM; Waltereit R; Jansen AC; de Vries PJ
Pediatr Neurol; 2023 Oct; 147():101-123. PubMed ID: 37598571
[TBL] [Abstract][Full Text] [Related]
12. Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism.
Davis PE; Peters JM; Krueger DA; Sahin M
Neurotherapeutics; 2015 Jul; 12(3):572-83. PubMed ID: 25986747
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R/4R tau aggregation.
Liu AJ; Lusk JB; Ervin J; Burke J; O'Brien R; Wang SJ
Acta Neuropathol Commun; 2022 Mar; 10(1):27. PubMed ID: 35241183
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric manifestations of tuberous sclerosis in a young man in a psychiatric hospital in Botswana: a case report.
Chabalala WT; Bojosi K; Maphane T; Olashore AA
J Int Med Res; 2024 Jan; 52(1):3000605231223450. PubMed ID: 38217425
[TBL] [Abstract][Full Text] [Related]
15. Extension of microglial activation is associated with epilepsy and cognitive dysfunction in Tuberous sclerosis complex: A TSPO-PET study.
Kagitani-Shimono K; Kato H; Soeda F; Iwatani Y; Mukai M; Ogawa K; Tominaga K; Nabatame S; Taniike M
Neuroimage Clin; 2023; 37():103288. PubMed ID: 36521371
[TBL] [Abstract][Full Text] [Related]
16. Tuberous sclerosis complex-associated neuropsychiatric disorders.
Marcinkowska AB; Tarasewicz A; Jóźwiak S; Dębska-Ślizień A; Szurowska E
Psychiatr Pol; 2022 May; ():1-20. PubMed ID: 36370437
[TBL] [Abstract][Full Text] [Related]
17. Seizure freedom but not epilepsy surgery is associated with fewer neuropsychiatric difficulties in patients with tuberous sclerosis.
Pearsson K; Eklund EA; Rask O; Compagno-Strandberg M
Epilepsy Behav; 2024 Jun; 157():109875. PubMed ID: 38824750
[TBL] [Abstract][Full Text] [Related]
18. Is tuberous sclerosis complex-associated autism a preventable and treatable disorder?
Curatolo P; Scheper M; Emberti Gialloreti L; Specchio N; Aronica E
World J Pediatr; 2024 Jan; 20(1):40-53. PubMed ID: 37878130
[TBL] [Abstract][Full Text] [Related]
19. Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem).
Heunis TM; Bissell S; Byars AW; Capal JK; Chambers N; Cukier S; Davis PE; De Waele L; Flinn J; Gardner-Lubbe S; Gipson T; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; Vanclooster S; van Eeghen AM; Waltereit R; Jansen AC; de Vries PJ
Front Psychiatry; 2022; 13():834628. PubMed ID: 35295772
[TBL] [Abstract][Full Text] [Related]
20. Perfect match: mTOR inhibitors and tuberous sclerosis complex.
Luo C; Ye WR; Shi W; Yin P; Chen C; He YB; Chen MF; Zu XB; Cai Y
Orphanet J Rare Dis; 2022 Mar; 17(1):106. PubMed ID: 35246210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]